Kirin Limited

KNBWY | OTC

Price Alert Chart Builder DCF Calculator

$18.04

+$0.03 (+0.17%)

At close: Sep 22, 2026, 3:51 PM ET

$18.03

-$0.01 (-0.06%)

After-hours: Sep 22, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

+0.17%

(1D)

Rating

Updated: Sep 16, 2026

39.9

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $14.4B

1D Range

18.04 18.17

52W Range

14.01 19.99

Valuation (TTM)

PE 40.46

PB 1.85

EV/EBITDA 10.66

Valuation (NTM)

Forward PE 12.39

Forward PEG 2.35

Price Target N/A

Cash Flow

FCF Yield 0.8%

SBC Adj. FCF Yield 0.8%

SBC Impact N/A

Margins

Gross Margin 48.4%

Operating Margin 5.8%

FCF Margin 0.7%

Growth (CAGR)

Revenue 3Y | 5Y 8.3% | 4.8%

Dil EPS 3Y | 5Y -22.1% | -10.5%

FCF 3Y | 5Y -42.8% | -24.6%

Returns

ROA 5.8%

ROE 15.3%

ROIC 7.8%

Financial Health

Net Debt

¥876.93B ($6.09B)

Current Ratio 1.48

Interest Coverage 14.03

Dividends

Div Yield 5.16%

Payout Ratio 1.4%

FCF Payout Ratio 337.8%

All Key Statistics

Loading financial charts...

Profile

A detailed description of the company is not yet available.

Sector n/a

Industry n/a

Employees n/a

IPO Date n/a

Website n/a

Fiscal Year n/a

Full Company Profile

Latest News

22 days ago · defenseworld.net

Arcadia Biosciences (NASDAQ:RKDA) and Kirin (OTCMKTS:KNBWY) Financial Survey

Kirin (OTCMKTS:KNBWY - Get Free Report) and Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) are both consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Analyst Recommendations This is a summary of current

3 months ago · globenewswire.com

The XLH Network and Kyowa Kirin Launch the XLH Community Guidebook to Help People Navigate Lifelong Journey with XLH

New online resource brings together practical information, community perspectives, and expert guidance tailored to people with XLH across ages and life stages New online resource brings together practical information, community perspectives, and expert guidance tailored to people with XLH across ages and life stages

11 months ago · zacks.com

Should Value Investors Buy Kirin (KNBWY) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Earnings

Next Earnings

Nov 10, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞